Clinical Trial Update: Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of a biological therapy following surgery and radiation for primary or recurrent Astrocytoma or Oligodendroglioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma
• Oligodendroglioma

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED